---
title: "Lovastatin - Hyperlipidemia"
sidebar: mydoc_sidebar
permalink: db00227-mesh-d006949-1.html
toc: false 
---


Path ID: `DB00227_MESH_D006949_1`
{% include image.html url="images/db00227-mesh-d006949-1.png" file="db00227-mesh-d006949-1.png" alt="db00227-mesh-d006949-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D008148 | lovastatin | Drug |
| DB:DBMET01698 | 6'beta-Hydroxylovastatin | ChemicalSubstance |
| UniProt:P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Protein |
| GO:0008610 | lipid biosynthetic process | BiologicalProcess |
| CHEBI:18059 | lipid | ChemicalSubstance |
| MESH:D006949 | Hyperlipidemia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Lovastatin | HAS METABOLITE | 6'Beta-Hydroxylovastatin |
| 6'Beta-Hydroxylovastatin | DECREASES ACTIVITY OF | 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase |
| 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase | POSITIVELY REGULATES | Lipid Biosynthetic Process |
| Lipid Biosynthetic Process | INCREASES ABUNDANCE OF | Lipid |
| Lipid | POSITIVELY CORRELATED WITH | Hyperlipidemia |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00227#BE0000574](https://go.drugbank.com/drugs/DB00227#BE0000574)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL503/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL503/)
  - [https://en.wikipedia.org/wiki/Lovastatin#Mechanism_of_action](https://en.wikipedia.org/wiki/Lovastatin#Mechanism_of_action)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/53232#section=Metabolism-Metabolites](https://pubchem.ncbi.nlm.nih.gov/compound/53232#section=Metabolism-Metabolites)
